Skip to content
healthcare.dev
Get a free key

Abecma

NDC 59572-515, idecabtagene vicleucel, suspension, from Celgene Corporation.

Product NDC
59572-515
Status
Listed
Labeler
Celgene Corporation
Dosage form
SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125736
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59572-515 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IDECABTAGENE VICLEUCEL300000000 1/1
Package NDCNDC-11Package
59572-515-01595720515011 SUSPENSION in 1 BAG (59572-515-01)
59572-515-02595720515021 SUSPENSION in 1 BAG (59572-515-02)
59572-515-03595720515031 SUSPENSION in 1 BAG (59572-515-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59572-515

Use it

Look up 59572-515 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59572-515 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59572-515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.